NASDAQ:INMD InMode (INMD) Stock Price, News & Analysis $17.13 +0.12 (+0.71%) As of 09:40 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrends About InMode Stock (NASDAQ:INMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get InMode alerts:Sign Up Key Stats Today's Range$17.04▼$17.1650-Day Range$16.63▼$19.5352-Week Range$14.87▼$26.80Volume37,832 shsAverage Volume381,805 shsMarket Capitalization$1.44 billionP/E Ratio9.26Dividend YieldN/APrice Target$22.60Consensus RatingHold Company OverviewInMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.Read More… InMode Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks57th Percentile Overall ScoreINMD MarketRank™: InMode scored higher than 57% of companies evaluated by MarketBeat, and ranked 438th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingInMode has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageInMode has only been the subject of 3 research reports in the past 90 days.Read more about InMode's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth9.25% Earnings GrowthEarnings for InMode are expected to grow by 9.25% in the coming year, from $1.73 to $1.89 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InMode is 9.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.38.Price to Earnings Ratio vs. SectorThe P/E ratio of InMode is 9.19, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 88.05.Price to Book Value per Share RatioInMode has a P/B Ratio of 2.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.14% of the outstanding shares of InMode have been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in InMode has recently increased by 1.52%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInMode does not currently pay a dividend.Dividend GrowthInMode does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.14% of the outstanding shares of InMode have been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in InMode has recently increased by 1.52%, indicating that investor sentiment is decreasing. News and Social Media1.9 / 5News Sentiment0.48 News SentimentInMode has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for InMode this week, compared to 6 articles on an average week.Search InterestOnly 9 people have searched for INMD on MarketBeat in the last 30 days. This is a decrease of -18% compared to the previous 30 days.MarketBeat Follows4 people have added InMode to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, InMode insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.92% of the stock of InMode is held by insiders.Percentage Held by Institutions68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InMode's insider trading history. Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Email Address INMD Stock News HeadlinesInMode Ltd. (NASDAQ:INMD) Receives $22.60 Consensus PT from BrokeragesJanuary 6 at 2:13 AM | americanbankingnews.comWith 57% institutional ownership, InMode Ltd. (NASDAQ:INMD) is a favorite amongst the big gunsDecember 30, 2024 | finance.yahoo.comDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. January 6, 2025 | Crypto 101 Media (Ad)InMode: Product Origination And Undervaluation Make The Stock A BuyDecember 12, 2024 | seekingalpha.comThe Returns On Capital At InMode (NASDAQ:INMD) Don't Inspire ConfidenceDecember 9, 2024 | uk.finance.yahoo.comInMode’s Strategic ‘Hold’ Amid Geopolitical Uncertainty and Demand SlowdownNovember 23, 2024 | markets.businessinsider.comWe Think You Can Look Beyond InMode's (NASDAQ:INMD) Lackluster EarningsNovember 7, 2024 | finance.yahoo.comInMode to Present at Upcoming Investor ConferencesNovember 6, 2024 | prnewswire.comSee More Headlines INMD Stock Analysis - Frequently Asked Questions How have INMD shares performed this year? InMode's stock was trading at $16.70 at the beginning of the year. Since then, INMD stock has increased by 1.9% and is now trading at $17.01. View the best growth stocks for 2025 here. How were InMode's earnings last quarter? InMode Ltd. (NASDAQ:INMD) issued its quarterly earnings data on Thursday, August, 1st. The healthcare company reported $0.34 EPS for the quarter, missing the consensus estimate of $0.38 by $0.04. The company's revenue for the quarter was down 24.6% compared to the same quarter last year. When did InMode's stock split? InMode's stock split on the morning of Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly minted shares were distributed to shareholders after the market closes on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Does InMode have any subsidiaries? InMode subsidiaries include these companies: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd.. When did InMode IPO? InMode (INMD) raised $75 million in an initial public offering (IPO) on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager. How do I buy shares of InMode? Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of InMode own? Based on aggregate information from My MarketBeat watchlists, some other companies that InMode investors own include Symbotic (SYM), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Voya Infrastructure, Industrials and Materials Fund (IDE), Voyager Therapeutics (VYGR), Humana (HUM), American Water Works (AWK) and Waste Connections (WCN). Company Calendar Last Earnings8/01/2024Today1/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:INMD CUSIPN/A CIK885988 Webwww.inmodemd.com Phone972-4909-7470FaxN/AEmployees480Year Founded2008Price Target and Rating Average Stock Price Target$22.60 High Stock Price Target$27.00 Low Stock Price Target$16.00 Potential Upside/Downside+32.9%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$1.85 Trailing P/E Ratio9.19 Forward P/E Ratio9.83 P/E GrowthN/ANet Income$197.92 million Net Margins36.26% Pretax MarginN/A Return on Equity21.46% Return on Assets19.19% Debt Debt-to-Equity RatioN/A Current Ratio10.68 Quick Ratio9.91 Sales & Book Value Annual Sales$423.75 million Price / Sales3.37 Cash Flow$2.06 per share Price / Cash Flow8.26 Book Value$6.68 per share Price / Book2.55Miscellaneous Outstanding Shares83,982,000Free Float78,170,000Market Cap$1.43 billion OptionableOptionable Beta2.12 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:INMD) was last updated on 1/6/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump plans $32 billion+ AI “Manhattan Project”Our research indicates ONE AI stock is poised to benefit the most. And even OpenAI founder Sam Altman admit...Behind the Markets | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredFirst JFK… next Elon?Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.